By AdminOK
Image from AstraZeneca website on FluMist.
by Brian Shilhavy
Editor, Health Impact News
In June of 2016 the Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) admitted that the live attenuated nasal influenza vaccine known as “FluMist” was not effective, and was not recommended for the 2016-2017 flu season. It was also not recommended for the current flu season (2017-2018).
The CDC’s own data showed that the nasal vaccine was not effective. The CDC press release in 2016 stated, “This three percent estimate means no protective benefit could be measured.”
Shortly after this announcement …read more
Source: Health Impact News
- Rating:
- Views:401 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr